Comparison of Factor VIII Transgenes Bioengineered for Improved Expression in Gene Therapy of Hemophilia A

Ítems similars

• Directed Engineering of a High-expression Chimeric Transgene as a Strategy for Gene Therapy of Hemophilia A
  per: Doering, Christopher B, et al.
  Publicat: (2009)
• Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
  per: Ide, Lucienne M., et al.
  Publicat: (2007)
• Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A
  per: Johnston, Jennifer M., et al.
  Publicat: (2012)
• Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII
  per: Spencer, H Trent, et al.
  Publicat: (2011)
• Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A
  per: Doering, Christopher B., et al.
  Publicat: (2018)